Hims & Hers Health, Inc.
Symbol: HIMS (NYSE)
56.52
▼ (-0.35%) -0.200
Company Description:
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Key Stats
- Today's Open: $56.307
- Today's High: $56.563
- Today's Low: $55.567
- Today's Volume: 54.95K
- Yesterday Close: $56.72
- Yesterday High: $59.1712
- Yesterday Low: $55.7812
- Yesterday Volume: 20.80M
- Last Min Volume: 212
- Last Min High: $56.544
- Last Min Low: $56.52
- Last Min VWAP: $56.52679
Company Profile
- Name: Hims & Hers Health, Inc.
- Website: https://www.forhims.com
- Listed Date: 2021-01-21
- Location: SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001773751
- SIC Code: 8011
- SIC description: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
- Market Cap: $12.82B
- Round Lot: 100
- Outstanding Shares: 226.02M
- Asset Type: CS
RECENT FILINGS FOR HIMS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | 4 | View |
| 2025-09-30 | 4 | View |
| 2025-09-29 | 144 | View |
| 2025-09-25 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-24 | 144 | View |
| 2025-09-22 | 144 | View |
| 2025-09-22 | 8-K | View |
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
Latest News on HIMS